Profil
Dr. Michael Spigarelli is a Chief Medical Officer at PsyBio Therapeutics Corp.
Dr. Spigarelli was previously employed as a Chairman by American Board of Clinical Pharmacology, Inc., a Vice President-Medical Affairs by Immucor, Inc., and a Chief Medical Officer by Lumen Bioscience, Inc. He received his MBA from the University of Utah and a doctorate degree from the University of Michigan.
Aktive Positionen von Michael Spigarelli
| Unternehmen | Position | Beginn |
|---|---|---|
| PSYBIO THERAPEUTICS CORP. | Technik-/Wissenschafts-/F&E-Leiter | 05.04.2021 |
Ehemalige bekannte Positionen von Michael Spigarelli
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUCOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services Operates health-related professional association | Vorsitzender | - |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. BiotechnologyHealth Technology Develops biologic drug platform | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Spigarelli
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Immucor, Inc.
Immucor, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells transfusion and transplantation diagnostics products | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Board of Clinical Pharmacology, Inc.
American Board of Clinical Pharmacology, Inc. Miscellaneous Commercial ServicesCommercial Services Operates health-related professional association | Commercial Services |
Lumen Bioscience, Inc.
Lumen Bioscience, Inc. BiotechnologyHealth Technology Develops biologic drug platform | Health Technology |
PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp. Pharmaceuticals: OtherHealth Technology Develops biosynthetic psychoactive compounds | Health Technology |
















